"NuvOx Therapeutics Receives FDA Fast Track Designation to NanO₂™ for the Treatment of Acute...
$200MM and Counting: What’s Next for the Movement to Invest in Women Entrepreneurs
07/15/2026 - Twenty-two years ago, Golden Seeds set out with a simple idea: women-led companies...
Moving Beyond Performative Entrepreneurship
Tucson, AZ 07-15-2026 - If Tucson is to transition from a generalized incubator of ideas into an...
iQure Pharma has received a research grant from the The Michael J. Fox Foundation for Parkinson’s Research
06/21/2026 - iQure Pharma, a clinical-stage biotech company developing first-in-class...
Delta Development Team Milestone Achievement
06/12/2026 - Delta Development Team, Inc., a multiple-time Desert Angels Portfolio company,...
iQure Pharma Inc. Chief Scientific Officer recently published
06/07/2026 - Second-Generation of Deuterium-Substituted Glutamate Uptake Enhancers Exhibit...
NuvOx Announces Positive Completion of 2nd Cohort in EXTEND-1b Trial
NuvOx Therapeutics (“NuvOx”), a clinical-stage biotechnology company developing oxygen...
Time to Update the Model – The Aging Angel Investment Thesis
A tiny minority of historical applicants that we turn down add us to their investor email list and...